BioNTech Investor Relations Material
Latest events
Q1 2025
BioNTech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioNTech SE
Access all reports
Segment Data
Access more data
Revenue by
Business area
Commercial revenues
Research & development revenues
Expenses by
Financials
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Additionaly its clinical development will target the treatment of infectious diseases, including prophylactic vaccine approach that includes mRNA. It is also developing various neoantigen-based immunotherapies in collaboration with Pfizer Inc.; other checkpoint molecules; and next-generation antigen receptor T-cell products. The company was formerly known as BioNtech Therapeutics GmbH. BioNTech SE was founded in 2008 and is headquartered in Mainz, Germany.
Key slides for BioNTech SE
Q1 2025
BioNTech SE
R&D Day 2024
BioNTech SE
)
Ticker symbol
BNTX
Country
🇺🇸 United States